M
Marek Lalli
Researcher at University of London
Publications - 10
Citations - 1724
Marek Lalli is an academic researcher from University of London. The author has contributed to research in topics: Tuberculosis & Cost–benefit analysis. The author has an hindex of 7, co-authored 10 publications receiving 1386 citations.
Papers
More filters
Journal ArticleDOI
Every Newborn: progress, priorities, and potential beyond survival
Joy E Lawn,Joy E Lawn,Hannah Blencowe,Shefali Oza,Danzhen You,Anne C C Lee,Anne C C Lee,Peter Waiswa,Peter Waiswa,Marek Lalli,Zulfiqar A Bhutta,Aluísio J D Barros,Parul Christian,Colin Mathers,Simon Cousens +14 more
TL;DR: National targets for 2035 are proposed for stillbirths and neonatal deaths, compatible with the under-5 mortality targets of no more than 20 per 1000 livebirths, and targets for 2030 are given.
Journal ArticleDOI
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models
Rein M G J Houben,Nicolas A Menzies,Tom Sumner,Grace H. Huynh,Nimalan Arinaminpathy,Nimalan Arinaminpathy,Jeremy D. Goldhaber-Fiebert,Hsien-Ho Lin,Chieh Yin Wu,Sandip Mandal,Surabhi Pandey,Sze-chuan Suen,Eran Bendavid,Andrew S. Azman,David W. Dowdy,Nicolas Bacaër,Allison S. Rhines,Allison S. Rhines,Marcus W. Feldman,Andreas Handel,Christopher C. Whalen,Stewart T. Chang,Bradley G. Wagner,Philip A. Eckhoff,James M. Trauer,James M. Trauer,Justin T Denholm,Emma S. McBryde,Emma S. McBryde,Ted Cohen,Joshua A. Salomon,Carel Pretorius,Marek Lalli,Jeffrey W. Eaton,Delia Boccia,Mehran Hosseini,Gabriela B. Gomez,Suvanand Sahu,Colleen Daniels,Lucica Ditiu,Daniel P. Chin,Lixia Wang,Vineet K. Chadha,Kiran Rade,Puneet Dewan,Piotr Hippner,Salome Charalambous,Alison D. Grant,Gavin J. Churchyard,Yogan Pillay,L. David Mametja,Michael E. Kimerling,Anna Vassall,Richard G. White +53 more
TL;DR: Major reductions in tuberculosis burden seem possible with current interventions, however, additional interventions, adapted to country-specific tuberculosis epidemiology and health systems, are needed to reach the post-2015 End TB Strategy targets at country level.
Journal ArticleDOI
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
Nicolas A Menzies,Gabriela B. Gomez,Gabriela B. Gomez,Fiammetta Bozzani,Susmita Chatterjee,Nicola L. Foster,Ines Garcia Baena,Yoko V. Laurence,Sun Qiang,Andrew M. Siroka,Sedona Sweeney,Stéphane Verguet,Nimalan Arinaminpathy,Nimalan Arinaminpathy,Andrew S. Azman,Eran Bendavid,Stewart T. Chang,Ted Cohen,Justin T Denholm,David W. Dowdy,Philip A. Eckhoff,Jeremy D. Goldhaber-Fiebert,Andreas Handel,Grace H. Huynh,Marek Lalli,Hsien-Ho Lin,Sandip Mandal,Emma S. McBryde,Emma S. McBryde,Surabhi Pandey,Joshua A. Salomon,Sze-chuan Suen,Tom Sumner,James M. Trauer,James M. Trauer,Bradley G. Wagner,Christopher C. Whalen,Chieh Yin Wu,Delia Boccia,Vineet K. Chadha,Salome Charalambous,Daniel P. Chin,Gavin J. Churchyard,Gavin J. Churchyard,Colleen Daniels,Puneet Dewan,Lucica Ditiu,Jeffrey W. Eaton,Alison D. Grant,Alison D. Grant,Alison D. Grant,Piotr Hippner,Mehran Hosseini,David Mametja,Carel Pretorius,Yogan Pillay,Kiran Rade,Suvanand Sahu,Lixia Wang,Rein M G J Houben,Michael E. Kimerling,Richard G. White,Anna Vassall +62 more
TL;DR: In general, expansion of tuberculosis services substantially reduced patient-incurred costs and, in India and China, produced net cost savings for most interventions under a societal perspective, and most intervention approaches seemed highly cost-effective.
Journal ArticleDOI
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.
Stéphane Verguet,Carlos Riumallo-Herl,Gabriela B. Gomez,Gabriela B. Gomez,Nicolas A Menzies,Rein M G J Houben,Tom Sumner,Marek Lalli,Richard G. White,Joshua A. Salomon,Ted Cohen,Nicola L. Foster,Susmita Chatterjee,Sedona Sweeney,Ines Garcia Baena,Knut Lönnroth,Diana Weil,Anna Vassall +17 more
TL;DR: Improvements in treatment for drug-sensitive and multidrug-resistant tuberculosis and expansion of access to tuberculosis care through intensified case finding in India and South Africa from 2016 to 2035 could lessen, although not eliminate, the catastrophic financial burden on affected households.
Journal ArticleDOI
TIME Impact – a new user-friendly tuberculosis (TB) model to inform TB policy decisions
Rein M G J Houben,Marek Lalli,Tom Sumner,Matthew J. Hamilton,Debora Pedrazzoli,F. Bonsu,Piotr Hippner,Yogan Pillay,Michael E. Kimerling,S. Ahmedov,Carel Pretorius,Richard G. White +11 more
TL;DR: TIME Impact enables national TB programmes (NTPs) and other TB policymakers to better understand their own TB epidemic, plan their response, apply for funding and evaluate the implementation of the response, and strengthens the decision-making process in general.